|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
MASI | Coleman Jon | Pres-WW OEM & Global Health | Dec 28 | Sale | 264.02 | 8,250 | 2,178,165 | 12,465 | Dec 30 04:21 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jul 06 | Sale | 235.00 | 1,250 | 293,750 | 12,465 | Jul 08 04:05 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Apr 14 | Sale | 190.00 | 2,000 | 380,000 | 12,465 | Apr 15 07:12 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Apr 15 | Sale | 197.50 | 4,000 | 790,000 | 12,465 | Apr 15 07:12 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Apr 01 | Sale | 140.00 | 2,000 | 280,000 | 11,201 | Apr 02 04:35 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Feb 25 | Sale | 130.00 | 2,000 | 260,000 | 11,201 | Feb 27 04:56 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Feb 27 | Sale | 135.00 | 2,000 | 270,000 | 11,201 | Feb 27 04:56 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jan 31 | Sale | 125.00 | 2,000 | 250,000 | 11,201 | Feb 01 04:03 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jan 18 | Sale | 120.00 | 2,000 | 240,000 | 11,201 | Jan 22 04:09 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jan 15 | Sale | 115.00 | 2,000 | 230,000 | 11,201 | Jan 16 04:08 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | May 03 | Sale | 93.75 | 50,000 | 4,687,500 | 9,201 | May 04 05:49 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Apr 23 | Sale | 90.00 | 24,000 | 2,160,000 | 9,201 | Apr 25 07:41 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Mar 29 | Sale | 87.50 | 29,303 | 2,564,012 | 9,201 | Apr 02 09:09 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jul 20 | Sale | 97.50 | 25,000 | 2,437,500 | 7,201 | Jul 24 04:32 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Apr 25 | Sale | 100.00 | 50,000 | 5,000,000 | 7,201 | Apr 26 04:27 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Feb 03 | Sale | 75.00 | 6,000 | 450,000 | 7,182 | Feb 07 04:26 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jan 25 | Sale | 72.50 | 1,525 | 110,562 | 7,182 | Jan 27 05:36 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jan 27 | Sale | 72.50 | 4,275 | 309,938 | 7,182 | Jan 27 05:36 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jan 19 | Sale | 72.50 | 100 | 7,250 | 7,182 | Jan 23 04:33 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jan 20 | Sale | 72.50 | 100 | 7,250 | 7,182 | Jan 23 04:33 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jan 10 | Sale | 70.00 | 6,000 | 420,000 | 7,182 | Jan 12 04:28 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Dec 21 | Sale | 67.50 | 4,000 | 270,000 | 459 | Dec 21 05:01 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Nov 07 | Sale | 60.00 | 6,000 | 360,000 | 459 | Nov 09 04:18 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Sep 06 | Sale | 60.00 | 300 | 18,000 | 459 | Sep 08 04:17 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Sep 07 | Sale | 60.00 | 5,700 | 342,000 | 459 | Sep 08 04:17 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Aug 04 | Sale | 56.82 | 22,000 | 1,250,000 | 459 | Aug 08 04:18 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Jun 01 | Sale | 50.00 | 4,000 | 200,000 | 459 | Jun 02 04:56 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | May 05 | Sale | 47.00 | 8,000 | 376,000 | 459 | May 06 04:47 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Apr 27 | Sale | 44.00 | 4,000 | 176,000 | 459 | Apr 29 04:18 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Dec 24 | Sale | 42.00 | 10,000 | 420,000 | 459 | Dec 28 04:12 PM |
MASI | Coleman Jon | Pres-WW Sales,Pro Svc,Med Affs | Nov 06 | Sale | 42.38 | 10,000 | 423,750 | 459 | Nov 10 04:51 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite